Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.

ABSTRACT:

Background

Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. allergen-specific immunotherapy (ASIT) is currently the only treatment option able to induce tolerance to the causative allergens.

Objective

To retrospectively establish the efficacy of ASIT in atopic dogs.

Animals

Client-owned (n  = 664) dogs with cAD presented between 2008 and 2018 to two dermatology referral clinics.

Materials and methods

Clinical records of atopic dogs were reviewed to obtain information including the results of the intradermal skin test and/or allergen-specific immunoglobulin (Ig)E serological results, the allergens included in the ASIT, concurrent symptomatic medications, and ASIT efficacy after at least 9 months.

Results

Exce

SUBMITTER: Fennis EEM 

PROVIDER: S-EPMC9544551 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature